Vidyalakshmi Chandramohan (Vidya Chandramohan)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 10

Top Topics

Tyrosine Kinase

Quality Control

Anaerobic Digestion

Top Venues

Science translational medicine

Applied microbiology and biotechnology

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Michael A Sun, Haipei Yao, Qing Yang, Christopher J Pirozzi, Vidyalakshmi Chandramohan, David M Ashley, Yiping He
Gene expression analysis suggests immunosuppressive roles of endolysosomes in glioblastoma. PloS one 19 (3) (2024)
Michael A Sun, Haipei Yao, Qing Yang, Christopher J Pirozzi, Vidyalakshmi Chandramohan, David M Ashley, Yiping He
Gene expression analysis suggests immunosuppressive roles of endolysosomes in glioblastoma. PloS one 19 (3) (2024)
Michael A Sun, Haipei Yao, Qing Yang, Christopher J Pirozzi, Vidyalakshmi Chandramohan, David M Ashley, Yiping He
Gene expression analysis suggests immunosuppressive roles of endolysosomes in glioblastoma. PloS one 19 (3) (2024)
Scott Parker, Charlotte McDowall, Luis Sanchez-Perez, Cristina Osorio, Patrick C Duncker, Aaron Briley, Adam M Swartz, James E Herndon, Yen-Rei A Yu, Roger E McLendon, Thomas F Tedder, Annick Desjardins, David M Ashley, Michael Dee Gunn, David S Enterline, David A Knorr, Ira H Pastan, Smita K Nair, Darell D Bigner, Vidyalakshmi Chandramohan
Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models. Science translational medicine 15 (682) (2023)
Scott Parker, Charlotte McDowall, Luis Sanchez-Perez, Cristina Osorio, Patrick C Duncker, Aaron Briley, Adam M Swartz, James E Herndon, Yen-Rei A Yu, Roger E McLendon, Thomas F Tedder, Annick Desjardins, David M Ashley, Michael Dee Gunn, David S Enterline, David A Knorr, Ira H Pastan, Smita K Nair, Darell D Bigner, Vidyalakshmi Chandramohan
Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models. Science translational medicine 15 (682) (2023)
Scott Parker, Charlotte McDowall, Luis Sanchez-Perez, Cristina Osorio, Patrick C Duncker, Aaron Briley, Adam M Swartz, James E Herndon, Yen-Rei A Yu, Roger E McLendon, Thomas F Tedder, Annick Desjardins, David M Ashley, Michael Dee Gunn, David S Enterline, David A Knorr, Ira H Pastan, Smita K Nair, Darell D Bigner, Vidyalakshmi Chandramohan
Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models. Science translational medicine 15 (682) (2023)
Xin Yu, Mikhail Dobrikov, Stephen T Keir, Matthias Gromeier, Ira H Pastan, Ralph Reisfeld, Darell D Bigner, Vidyalakshmi Chandramohan
Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors. PloS one 14 (1) (2019)
Vidyalakshmi Chandramohan, Xuhui Bao, Xin Yu, Scott Parker, Charlotte McDowall, Yen-Rei Yu, Patrick Healy, Annick Desjardins, Michael D Gunn, Matthias Gromeier, Smita K Nair, Ira H Pastan, Darell D Bigner
Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations. Journal for immunotherapy of cancer 7 (1) (2019)
Michael C Brown, Eda K Holl, David Boczkowski, Elena Y Dobrikova, Mubeen Mosaheb, Vidyalakshmi Chandramohan, Darell D Bigner, Matthias Gromeier, Smita K Nair
Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs. Science translational medicine 9 (408) (2018)
Vidyalakshmi Chandramohan, Charles N Pegram, Hailan Piao, Scott E Szafranski, Chien-Tsun Kuan, Ira H Pastan, Darell D Bigner
Production and quality control assessment of a GLP-grade immunotoxin, D2C7-(scdsFv)-PE38KDEL, for a phase I/II clinical trial. Applied microbiology and biotechnology 101 (7) (2016)